Next Article in Journal
Heat Transfer in Carbon-Nanotube Dispersions: A Simulation Study of the Role of Nanotube Morphology and Connectivity
Previous Article in Journal
Biomass-Derived-Carbon-Supported Spinel Cobalt Molybdate as High-Efficiency Electrocatalyst for Oxygen Evolution Reaction
Previous Article in Special Issue
Some Aspects and Convergence of Human and Veterinary Drug Repositioning
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning

1
Department of Functional Sciences, Faculty of veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liege, Belgium
2
Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2R3, Canada
3
Biochemical Genetics Laboratory, Human Genetics, CHU Sart Tilman, University of Liège, 4000 Liege, Belgium
4
Laboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Sart Tilman, 4000 Liege, Belgium
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(20), 4954; https://doi.org/10.3390/molecules29204954
Submission received: 29 July 2024 / Revised: 3 October 2024 / Accepted: 12 October 2024 / Published: 19 October 2024
(This article belongs to the Special Issue Veterinary Drugs—2nd Edition)

Abstract

:
Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPrG) are protoxins produced by Sapindaceae plants, particularly Acer pseudoplatanus, and are responsible for causing atypical myopathy (AM) in equids. These protoxins metabolise into toxic compounds, such as methylenecyclopropylacetyl-CoA (MCPA-CoA), which alters energy metabolism and induces severe rhabdomyolysis. Currently, no specific treatment exists for this poisoning, in vitro models fail to reproduce HGA’s toxic effects on equine primary myoblasts, and mammalian models are impractical for large-scale drug screening. This study aimed to develop a zebrafish embryo model for screening therapeutic compounds against AM. Zebrafish embryos were exposed to various concentrations of HGA, MCPrG, and methylenecyclopropylacetate (MCPA) for 72 h. MCPrG did not induce toxicity, while HGA and MCPA showed median lethal concentration (LC50) values of 1.7 µM and 1 µM after 72 h, respectively. The highest levels of the conjugated metabolite MCPA–carnitine were detected 24 h after HGA exposure, and the acylcarnitines profile was highly increased 48 h post-exposure. Isovaleryl-/2- methylbutyrylcarnitine levels notably rose after 24 h, suggesting potential exposition biomarkers. Glycine and carnitine effectively reduced mortality, whereas riboflavin showed no protective effect. These findings suggest that the zebrafish embryo represents a valuable model for identifying therapeutic compounds for Sapindaceae poisoning.

1. Introduction

Invasive or newly encountered flora present an emerging risk of toxic exposure not only to grazing fauna but also to humans through both direct and indirect pathways, the latter via the consumption of animal-derived products such as milk and meat [1]. Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPrG) are protoxins synthesised by plants of the Sapindaceae family such as lychee (Litchi chinensis), ackee (Blighia sapida) [2,3,4] and some maple trees notably (Acer pseudoplatanus) [2]. The ingestion of A. pseudoplatanus (sycamore maple) components, known for its association with emerging pasture-related toxicities, triggers atypical myopathy (AM) in equines. Toxicity is attributed to all components of the plant, including fruits, leaves, and seedlings [5,6,7,8]. Atypical myopathy is characterised as an acute rhabdomyolysis syndrome, triggered by the consumption of HGA and MCPrG, compounds found in the seeds and seedlings of A. pseudoplatanus. Upon ingestion, these protoxins undergo metabolic conversion into methylenecyclopropylacetyl-CoA (MCPA-CoA) and methylenecyclopropylformyl-CoA (MCPF-CoA), respectively. These metabolites exert their toxicological effects by the inhibition of the acyl-CoA dehydrogenases of short- and medium-chain, inhibiting multiple stages of β -oxidation, thus disrupting lipid metabolism. These inhibitions led to a strong increase in the corresponding acylcarnitines in blood and skeletal muscles [9,10]. Currently, supportive treatments such as the administration of vitamins and antioxidants have been shown to enhance the survival of horses affected by AM [11]. However, no specific treatment currently exists for this poisoning, leading to a lethality rate between 61 and 74% [12,13]. Thus, the development of an efficient drug screening model would be highly valuable to reduce the impact of the poisoning.
Since the discovery of toxins primarily associated with Jamaican vomiting sickness, various in vitro models [14] and in vivo models (e.g., rabbit, mice, rat) [15,16,17] have been utilised to characterise the toxicity of HGA and methylenecyclopropylacetate (MCPA). As part of AM investigations, the cytotoxicity of these toxins has also been studied using in vitro models such as cultured equine primary myoblasts [18,19,20]. Notably, these studies revealed that, while MCPA exhibited cytotoxic effects, HGA at concentrations of 1 mM and 10 mM did not induce cytotoxicity in equine primary myoblasts [19,20], and thus, does not induce the toxic effects observed in vivo. This failure to replicate the full pathophysiological impact of HGA in vitro highlights the need for an alternative model capable of better simulating the intoxication process. In addition, while mammalian models, such as mice and rats [15,16,17], can reproduce the toxicity observed in equines, they are not practical for large-scale pharmaceutical screening. In fact, ethical concerns, logistical challenges, and the high costs associated with maintaining and conducting experiments on large numbers of mammals render them unsuitable for high-throughput drug discovery [21]. This has resulted in a gap in models suitable for characterising and understanding the cytotoxicity of A. pseudoplatanus toxins.
Various models have been developed to address these challenges, including complex in vitro models [22], Caenorhabditis elegans [23], or zebrafish. Zebrafish are a powerful tool in toxicity assays, offering advantages like genetic similarity to humans, transparent embryos, and rapid development as well as easy to maintain, and allow for rapid, high-throughput screening [24,25,26]. These features facilitate the efficient, real-time observation of toxic effects across environmental and pharmaceutical studies. Their use in high-throughput screenings offers a cost-effective method for assessing compound toxicity, with direct exposure to the substances facilitated by the larvae’s permeability. This model has proven valuable in identifying organ-specific toxicities and mechanisms of action, enhancing our understanding of the potential human health impacts and contributing to safer chemical and therapeutic development [27,28]. Furthermore, zebrafish are a valuable tool in drug discovery, with applications in drug screening, target identification, pharmacology, and toxicology [29,30,31,32]. In the field of toxicology, zebrafish can be used to identify the molecules with protective effects against various toxins [32,33], making them an ideal model for evaluating potential therapeutic compounds against Sapindaceae poisoning.
This study aimed to longitudinally investigate the effects of HGA, MCPrG, and MCPA in zebrafish larvae and to develop a drug screening model for identifying therapeutic compounds.

2. Results

2.1. Zebrafish Embryo Acute Toxicity Test

Prior to conducting the zebrafish embryo acute toxicity tests (zFETs), a range finding test (RFT) was performed before the zFET, enabling the investigation of the suitable concentrations for the zFET and to assess the solubilisation and resorption of toxic compounds (i.e., HGA, MCPrG, and methelynecyclopropylacetate also known as MCPA) in solvents comprising E3 medium, 1% dimethyl sulfoxide (DMSO) and 1% ethanol. No difference was observed regarding the sub-lethal and lethal effects when toxic compounds (i.e., HGA, MCPrG, and MCPA) were dissolved 1% DMSO or 1% ethanol in comparison versus in E3 medium. Therefore, the absorption of toxic molecules was supposed to be similar between solvents leading to solubilisation in E3 medium for the zFET. Details regarding the tested concentrations of the RFT are displayed in (Supplementary Table S1).
The zFET was initiated to expose larvae to toxic compounds (i.e., HGA, MCPrG, and MCPA) at 24 hpf. The median lethal concentration (LC50) and the median effective concentration (EC50) were determined for the three compounds at different time points, specifically at 24, 48, and 72 h post-exposure (Figure 1). Despite the increase in MCPrG concentrations up to 5000 μ M, no sub-lethal or lethal effects were observed throughout the RFT, even extending to 96 h post-exposure. This absence of observable effects precluded the application of the zFET assay for MCPrG. Similarly, no effects were observed for HGA intoxication after 24 h. Therefore, it was not possible to determine LC50 and the EC50 values MCPrG and HGA after 24 h post-exposure.
Dose-dependent mortality was observed for both HGA and MCPA with cumulative mortality rates increasing over time (Figure 1). Observations revealed a progressive increase in both the incidence and severity of sub-lethal effects throughout the duration of the toxic exposure. The lethal and sub-lethal effects were similar between both HGA and MCPA. Notably, no adverse effect was observed at 24 h post-exposure with HGA. In contrast, significant effects manifested within a few hours following a high concentration of MCPA in the RFT. The lethal effects as described in OECD guideline included egg coagulation and lack of heartbeat, with the egg coagulation being exclusively associated with MCPA, given the fact that larvae died at 72 hpf with HGA (i.e., 48 h post-exposure). The primary lethal point was lack of heartbeat. Among the sub-lethal effects, bradycardia were predominantly observed, followed by pericardial oedema, and cardiac arrhythmia, in decreasing order of frequency.
Thanks to a the four-parameter log-logistic function, the LC50 and EC50 values were determined. HGA-induced toxicity appeared after 48 h, primarily characterised by a bradycardia and increased mortality. The severity of these effects remained relatively consistent, fluctuating between 40% and 80% for HGA concentrations ranging from 3.125 to 50 μ M. Notably, the effects approached 100% lethality at concentrations of 100 and 200 μ M HGA (Figure 1 panel A). After 72 h, the estimated EC50 was 2.07 μ M, while the estimated LC50 was 1.66 μ M, although this finding was not statistically significant (Figure 1 panel A). In comparison, exposure to MCPA resulted in sub-lethal effects in approximately 30% of the specimens at 24 h post-exposure with a concentration of 10 μ M. By 48 h, the EC50 and LC50 values were calculated to be 1.35 and 1.82 μ M, respectively, and by 72 h, these values decreased to 0.989 and 1.33 μ M, respectively (Figure 1 panel B). Minimal to no effects were observed at concentrations below 0.3125 μ M.

2.2. Toxin, Toxic Metabolite Dosage, and Acylcarnitines Profile

Longitudinal monitoring of HGA, MCPA–carnitine, and acylcarnitines profile was undertaken to elucidate the kinetics of intoxication (Figure 2). After HGA exposure, the concentration of HGA in zebrafish larvae exhibited a decline, with the exception observed at the 100 μ M HGA exposure level (Figure 2 panel A). The protoxin HGA was metabolised into MCPA in zebrafish larvae. The most pronounced elevations in MCPA–carnitine concentrations were observed after 24 h at HGA concentrations exceeding 6 μ M, and after 48 h for a 1.56 μ M HGA concentration (Figure 2 panel B). Following MCPA exposure, HGA was undetectable (Figure 2 panel C). The peak levels of MCPA–carnitine were recorded after 48 h for exposures to 1.25 and 0.07 μ M MCPA. In contrast, at a 10 μ M MCPA concentration, the MCPA–carnitine level was exceptionally high initially at 0 h and exhibited a decrease over the course of 72 h (Figure 2 panel D).The concentration of HGA in the E3 medium reduced over time and was proportional to the initial HGA concentrations exposure (Figure 2 panel E), whereas the MCPA–carnitine levels in the E3 medium increased over time and were proportional to the initial HGA concentrations exposure (Figure 2 panel F). However, similar MCPA–carnitine concentrations were measured for exposures to 6.25 and 100 μ M HGA.
The goal of this analysis was to evaluate the kinetics of the acylcarnitines profile after HGA exposure. The kinetics of the acylcarnitines profile were analysed following the exposure of zebrafish larvae to 100 μ M HGA. Notably, a significant increase in acylcarnitines with a four-carbon chain length was observed after 48 h, particularly for butyryl-/isobutyrylcarnitine (C4), while the magnitude of the increase was more moderate for hydroxy butyryl-/isobutyrylcarnitine (C4-OH) and succinyl-/methylmalonylcarnitine (C4-DC), (Figure 3 panel A). Interestingly, at 24 and 72 h post-exposure, butyrylcarnitine levels remained relatively elevated, whereas levels of C4-OH and C4-DC experienced a marked decrease after 72 h (Figure 3 panel A). The kinetics of isovaleryl-/2-methylbutyrylcarnitine (C5) showed a pronounced increase 24 h after exposure, maintaining elevated levels at 48 h (Figure 3 panel B). Conversely, other five-carbon length acylcarnitines, such as tiglylcarnitine (C5:1), hydroxy isovalerylcarnitine (C5-OH), and glutarylcarnitine (C5-DC), remained close to the baseline levels observed prior to exposure (Figure 3 panel B). Among the even-numbered acylcarnitines, hexanoylcarnitine (C6), octanoylcarnitine (C8), and decanoylcarnitine (C10) levels increased after 48 h (Figure 3 panel C). Among the short- and medium-chain acylcarnitines, C4 and C5 exhibited the most significant increases (Figure 3 panel D).

2.3. Short-Term Toxicity Test and Locomotor Behaviour Assessment

Total swimming distance was investigated to detect short-term toxicity in larvae exposed to various concentrations of MCPA (Figure 4). Twenty minute exposure of high concentrations of MCPA did not reduce the swimming distance during dark photocycle compared to the control (Supplemental Figure S2 panel A). However, twenty-four hours of exposure of high concentrations of MCPA significantly reduced the swimming distance during dark photocycle (Figure 4 panel A). The larvae exposed to 3,4 dichloroaniline (positive control), 40 and 20 µM MCPA for 24 h were dead (Figure 4 panel A). Twenty minutes to two hours of exposure to low concentrations of MCPA did not reduce the swimming distance during the dark photocycle (Supplemental Figure S2 panels B–D). Twenty-four hours of exposure to 1.25 µM and 0.15 µM of MCPA significantly reduced the swimming distance during dark photocycle compared to the control (Figure 4 panel B,D).

2.4. Impact of Riboflavin, Carnitine, and Glycine on Zebrafish Larval Mortality under MCPA and HGA Exposure

The protective effects of riboflavin, carnitine, and glycine were evaluated after 72 h of co-exposure with MCPA or HGA (Figure 5). Positive controls consisted of larvae exposed to toxic compounds only, while negative controls consisted of larvae in E3 medium and with the test molecules alone.
Riboflavin did not show a protective effect when co-treated with either MCPA or HGA, while carnitine and glycine decreased mortality under both conditions (Figure 5). For carnitine, all surviving larvae exhibited sub-lethal effects (bradycardia or cardiac oedema) with MCPA (11/11), whereas one out of three did so with HGA. Glycine demonstrated greater protective efficacy, with fewer surviving larvae showing sub-lethal effects with MCPA (6/13), and none with HGA (0/8).
Most of the positive controls succumbed within 72 h. Those that survived displayed significant sub-lethal effects and were likely to die shortly thereafter. Among the negative controls, three out of ten larvae in the glycine group and one in the riboflavin group died after 72 h for reasons that remain unknown.

3. Discussion

In this study, we developed a zebrafish embryo model to assess the toxic effects of protoxins derived from A. pseudoplatanus and to screen potential therapeutic compounds for Sapindaceae poisoning. Zebrafish embryos at 24 hpf were exposed to various concentrations of HGA, MCPrG, and MCPA. The longitudinal design of the study allowed us to monitor both lethal and sub-lethal effects, including the quantification of HGA and MCPA–carnitine, as well as acylcarnitines profile. Behavioural responses were also recorded, providing an additional dimension of toxicological insight. Lastly, the potential protective effect of riboflavin, carnitine, and glycine, three supportive treatments used in AM, was evaluated using this model.
Our findings confirm that HGA and MCPA induce significant toxic effects in zebrafish larvae, consistent with their known role in inhibiting fatty acid metabolism [16,34]. Apart from death, two key sub-lethal toxicity endpoints were identified: diminished cardiac rate and cardiac oedema. Under normal conditions, zebrafish larvae exhibit heart rates between 120 and 180 beats per minute [35], but exposure to HGA and MCPA reduced heart rates to below 80 beats per minute. Cardiac oedema was also commonly observed, a condition known to be induced by other toxic compounds [36,37]. Larvae with cardiac oedema typically exhibited reduced heart rates. These findings align with reports of cardiac signs occasionally seen in horses affected by AM [38]. Additional signs, such as tremors, shivering, and dorsal axis curvature [39], were occasionally noted but were not classified as sub-lethal effects, as they were also sporadically observed in control groups.
Previous studies in mammals have demonstrated that HGA inhibits acyl-CoA dehydrogenases [14,40,41], leading to the accumulation of toxic metabolites and the disruption of energy production, which can be monitored through the acylcarnitines profile [9,42]. In our study, the kinetics of HGA, MCPA–carnitine, and the acylcarnitines profile in the zebrafish whole body were notably similar to those observed in human serum [43], supporting several key insights. Firstly, following HGA exposure, the highest concentrations of HGA in zebrafish larvae were detected shortly after exposure, aligning with reports of elevated HGA serum levels in humans one hour after ackee ingestion. Interestingly, larvae exposed to the highest concentration (100 µM) displayed an unexpected increase in internal HGA levels over time, while lower concentrations showed the expected decline due to metabolisation into MCPA-CoA. Although this discrepancy remains unexplained, it suggests that potential metabolic or absorption dynamics from the media that require further investigation. The concurrent decrease in HGA concentration in the E3 medium supports ongoing metabolism or uptake by the larvae. While technical factors, such as the loss of the chorion [44], may influence dosage measurements, these findings provide new insights into HGA kinetics in zebrafish larvae. Secondly, the metabolism of HGA into MCPA–carnitine started within the first 24 h, leading to high MCPA–carnitine levels observed 24 h after HGA exposure, particularly at concentrations above 30 nmol/L. These levels decreased over time at higher HGA concentrations exposure (100 and 24 µM), while remaining steady between 20 and 10 nmol/L for lower exposure concentrations (6.25 and 1.58 µM). The increase in MCPA–carnitine levels coincided with a decrease in HGA concentrations in both the larvae and the E3 medium, mirroring human studies where HGA serum concentrations similarly declined 24 h after ackee fruit consumption [43]. Thirdly, the acylcarnitines profile revealed significant metabolic disruptions, especially in butyryl-/isobutyrylcarnitine (C4) and isovaleryl-/2-methylbutyrylcarnitine (C5), which peaked 48 h post-HGA exposure. Among short- and medium-chain acylcarnitines, C5 showed a more significant increase and may serve as a more predictive biomarker than C4 of HGA exposition. While C4 levels remained stable at 24 and 72 h post-exposure, C5 levels exhibited more dynamic fluctuations during this period. Although differences in dosing methods and sample matrices exist, the overall kinetic patterns of HGA, MCPA–carnitine, and acylcarnitine profiles in zebrafish larvae are closely similar to those seen in human serum.
Methylenecyclopropylglycine (MCPrG) did not induce toxic effects in zebrafish larvae, even at a concentration of 5 mM after 72 h of exposure. Previous studies in mammals, including mice and rats, demonstrated the toxic effects of MCPrG [16,17], with the primary difference being the route of administration (intraperitoneal or oral versus immersion in medium). In our study, absorption was assessed by comparing the dissolution of toxic molecules in E3 medium, 1% dimethyl sulfoxide (DMSO), and 1% ethanol, with no significant differences in mortality among the solvents. The chorion may have played a protective role, as it can limit the passage of molecules based on size and polarity [45]. While the zebrafish chorion is generally permeable to small molecules under 3000 Da [45,46,47,48,49], whether MCPrG crosses it remains unconfirmed. Most embryos lost their chorion between 48 and 72 hpf, which might have influenced absorption. However, no differences in mortality were observed with other toxins (HGA, MCPA) between larvae with or without chorion during the method development. Metabolism of both A. pseudoplatanus toxins relies on branched-chain amino acid aminotransferase and the branched-chain α -ketoacid dehydrogenase complex [16], but it is unknown whether metabolic differences exist between zebrafish and humans. Quantifying MCPF–carnitine in both medium and whole body could provide further insights. Additionally, the 72-h observation period may have been insufficient, as the toxic effects of HGA became evident only after 48 h, fully manifesting at 72 h.
Behavioural analysis showed that high concentrations of MCPA significantly reduced the swimming distance during the dark photocycle, a response not immediately observed after exposure. Additionally, high MCPA concentrations altered movement patterns and induced thigmotaxis, the tendency of an animal to stay in contact with a vertical surface [50], a behaviour typically associated with anxiety [51]. This effect was prominent after 24 h of exposure (Figure 4 panel A; Figure S3). In contrast, lower concentrations of MCPA did not significantly impact swimming distance or behaviour, suggesting a concentration-dependent effect of MCPA on zebrafish larvae.
One limitation of this study is the use of 24 hpf zebrafish larvae for toxin exposure, instead of the recommended 0–3 hpf stage as outlined by OECD guidelines [52]. Initially, we conducted experiments using 0.5–3 hpf embryos, but encountered significant challenges in consistently identifying fertilised eggs. Approximately 5% of the eggs were unfertilised, introducing variability across experimental conditions and compromising reproducibility, particularly with large sample sizes of around 2000 eggs per experiment. Additionally, manual observation under the microscope is time-consuming and challenging, hindering the ability to ensure the precise timing of exposure for each egg, which introduced further variability. To improve reproducibility, we opted to begin exposures at 24 hpf, when fertilised and unfertilised eggs could be more easily distinguished using fluorescence from methylene blue in the E3 medium. Although this modification may bypass potential toxic effects during the first 24 h, our primary goal was to ensure reliable data for therapeutic compound screening, and 24 hpf embryos better reflect the physiology of developed animals affected by Sapindaceae poisoning. Furthermore, while this adaptation limits our ability to assess certain endpoints (e.g., coagulation, somite formation, tail detachment), our control larvae under identical conditions displayed no significant sub-lethal or lethal effects, suggesting that the use of 24 hpf embryos remains suitable for our objectives. However, future studies should consider including earlier exposure stages for a more comprehensive toxicological profile.
Another limitation of this study is the lack of replication for the quantification of HGA, MCPA–carnitine, and acylcarnitines profile. Therefore, these results should be interpreted with caution. To increase robustness, the experiments would need to be repeated at least three times to generate biological replicates. However, as the primary focus of the study was not the detailed quantification of these profiles but rather the identification of therapeutic compounds, we chose not to perform multiple replicates. We prioritised the screening of potential therapeutic agents, which we believe will have a greater positive impact on treating poisoned animals.
The protective effects of three molecules (riboflavin, glycine, and carnitine), known for their potential protective roles in AM, were evaluated in this study [12,53,54]. Riboflavin did not demonstrate any protective effect in our experiments, which aligns with a previous in vitro study where co-treatment with riboflavin did not protect primary myoblasts exposed to MCPA [20]. However, a protective effect of riboflavin on liver mitochondria in rats was observed when administered prior to HGA exposure [55]. Therefore, the protective potential of riboflavin in intoxicated mammals remains unclear.
In contrast, carnitine and glycine exhibited protective effects in zebrafish larvae exposed to both HGA and MCPA (Figure 5). Both molecules are capable of binding MCPA to form MCPA–carnitine or MCPA–glycine complexes, facilitating the elimination of MCPA [34,43,54]. These findings are consistent with a previous in vitro study, where co-treatment with carnitine and glycine protected primary myoblasts exposed to MCPA [20]. Although most of the surviving larvae displayed sub-lethal effects, the delay in lethality is notable in the context of Sapindaceae poisoning, as horses that survive AM typically recover fully. These preliminary results support the recommendation to supplement with carnitine and glycine during Sapindaceae poisoning [54]. However, further studies are needed to validate these protective effects in other animal models and to explore the underlying mechanisms in more detail.

4. Materials and Methods

4.1. Materials

The protoxins HGA and MCPrG were obtained from Toronto Research Chemicals (North York, ON, Canada), while MCPA was purchased from Sigma-Aldrich (Overijse, Belgium) (Table 1).

4.2. Zebrafish Husbandry

Zebrafish (Danio rerio) of the AB wildtype strain were maintained in a Techniplast rearing system at 28 °C under a 14 h/10 h light/dark photocycle within the zebrafish facility at GIGA-Research, University of Liège. Following breeding, fertilised eggs were maintained in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) in Petri dishes at 28 °C until 24 h post-fertilisation (hpf). All procedures adhered to animal protection guidelines and were approved by the Animal Ethics Committee of the University of Liège.

4.3. Zebrafish Embryo Acute Toxicity Test

A RFT was initially conducted using ten individuals in a single experiment to define the effective concentrations of HGA, MCPA, and MPCrG (Supplementary Table S1). Ten eggs per chemical concentration, sixteen eggs for the negative control (E3), and twenty eggs for the positive control (4 mg/L of 3,4 dichloroaniline, Sigma Aldrich, Overijse, Belgium) with one egg per well in 100 μ L of solution were exposed in 96-well plates from approximately two-cell stage to 96 hpf without renewing the drug solutions. To assess whether the absorption of HGA, MCPA, and MCPrG was enhanced, 1% ethanol or 1% DMSO was added to the test solutions containing these toxic compounds.
Zebrafish embryo acute toxicity tests (zFETs) were performed in triplicate according to the OECD test guidelines [52] with a major modification: the eggs were intoxicated 24 h after breeding. Twenty fertilised eggs per concentration and four eggs for the negative control (E3) were exposed from approximately 24 hpf until 96 hpf with one egg per well in 24 well-plates (2 mL per well) or in 96 well-plates (120 μ L per well) for MCPA and HGA, respectively. To avoid evaporation, all the plates were closed with an adhesive seal (VWR, Leuven, Belgium) and the edge wells of 96-well plates were filled with 300 μ L of E3. In addition, a container filled with water was put in the incubator. Embryos were monitored every day from 24 until 96 hpf. Four apical points were monitored for mortality, as described in the OECD test guidelines: (i) coagulation; (ii) lack of somite formation; (iii) lack of detachment of the tail; and (iv) lack of heartbeat. Sub-lethality was characterised by slow heartbeat (i.e., less than 60 beats per minute) and cardiac oedema. Both mortality and sub-lethal effects enabled one to determine the LC50 and the EC50, respectively. Each exposure assay was always observed by the same observers (i.e., C.P.W. or N.P.) all along the experiment, avoiding inconsistent monitoring.

4.4. Acylcarnitines Profile

Individual larvae were initially isolated in separate wells and then pooled into groups of twenty per concentration, including negative controls (E3), and sampled at 0, 24, 48, and 72 h post-exposure. This approach not only mitigates intra-individual variability but also enables the analysis to remain within the quantification limits of the assays performed via liquid chromatography–mass spectrometry (LC-MS). This experiment was performed in one replicate. The larval stage occurs between 48 and 96 hpf, when it loses their chorion. The solution containing protoxins or toxic compounds was applied once without renewing solution all along the exposure. For the sampling collection, E3 medium was removed and two drops of tricaine methanesulfonate (MS-222, Sigma-Aldrich, 400 mg/L) were used for sacrifice. Tricaine methanesulfonate was removed and 200 μ L of methanol 50% was added. Embryos/larvae were crushed using 10 back and forth processes through a 26 G and a 22 G needles. Samples were centrifuged at 2660 rcf. The supernatant was put at −20 °C for the LC-MS analysis. Hypoglycin A was quantified on the supernatant using a validated methodology based on an aTRAQ kit for the amino acid analysis of physiological fluids (Sciex, Framingham, MA, USA), as mentioned in Boemer et al. [56]. MCPA–carnitine and acylcarnitines profile concentrations in serum were determined by tandem mass spectrometry (MS/MS), as described previously [9].

4.5. Short-Term Toxicity Test and Locomotor Behaviour Assessment

The behaviours of individual exposed and control larvae were analysed using the ZebraBox® recording chamber (Viewpoint, Lyon, France). After breeding, eggs were collected into E3 medium and maintained at 28 °C. On the following day, unfertilised eggs were removed and the E3 medium was changed daily. At 72 hpf, larvae were exposed to low or high MCPA concentrations, in 96-well plates (one larva and 120 μ L per well). After exposure, the larvae were placed on the recording platform for tracking locomotor behaviour using the Zebrabox® (Viewpoint, Lyon, France). The ZebraLab software (Viewpoint Life Sciences, Lyon, France) was used to program the light cycle protocol, which lasted one hour with 20 min warm-up followed by two cycles of a 10 min dark/light photocycle. Measurements were taken 20 min post-exposure and at one, two, three, and 24 h post-exposure. Twelve or twenty-four larvae per concentration were monitored. This experiment was performed in one replicate.
Zebrafish larvae react to an instantaneous shift from 100% to 0% illumination by markedly increasing their locomotor activity. Toxic compounds can significantly reduce this response, causing notably decreased activity during dark periods as compared to control. The assays were performed in the early afternoon between 12:00 and 15:00, as larvae tend to respond to illumination changes with the least variance during that time of day [57]. Locomotor data were aggregated in 600-second bins for each individual, and separated into nine locomotor activity variables as published by Pohl and collaborators [58].

4.6. Impact of Riboflavin, Carnitine, and Glycine on Zebrafish Larval Mortality under MCPA and HGA Exposure

The experimental conditions were consistent with those previously described in the zFET protocol. Experiments were conducted in biological triplicate in 24-well or 96-well plates with final volumes of 2 mL for MCPA and 200 µL for the HGA assessment, respectively. Each plate included at least two larvae either exposed to the test molecules alone or to the test molecules combined with the toxic compounds, multiple larvae exposed only to the toxic compounds as positive controls, and several larvae maintained in E3 medium as negative controls. Multiple plates were utilised for the experiments. Riboflavin, glycine, and carnitine (CAS numbers: 83-88-5, 56-40-6, and 541-15-1, respectively) were obtained from Sigma-Aldrich (Overijse, Belgium) and added simultaneously with the toxic compounds, 2 µM of MCPA or 10 µM of HGA. The final concentration in the well for riboflavin, glycine, and carnitine was 100 µM, 10 mM, and 100 µM, respectively. Lethal and sub-lethal effects were observed every 24 h, as previously described.

4.7. Statistical Analysis

All data were exported and analysed using R (version 4.3.1 2023-06-16) [59] with the RStudio interface [60]. For the zFET, lethal and sub-lethal concentrations were calculated using the four-parameter log-logistic function using the drc R package [61]. For the dosage of HGA, MCPA–carnitine and acylcarnitines profile, plots were performed using the ggplot2 R package [62].
For locomotor analysis, data were analysed by adapting the R script published by Pohl and collaborators [58]. Briefly, individual total swimming distance (defined as smldist + lardist) during 10 min and light and dark periods were summarised. Control and treatment mean ± standard deviation were then plotted using the ggplot2 package [62]. Locomotor activity data (i.e., total swimming distance during dark conditions) were summarised for each individual embryo–larvae replicate and analysed using one-way analysis of variance (ANOVA) followed by normal distribution evaluation. Significant treatment effects were assessed by Dunnett’s post hoc test using the multcomp R package [63]. Treatment groups with p-values of <0.05 (*), <0.01 (**), and <0.001 (***) were considered as significantly deviating from the control mean.

5. Conclusions

In summary, we developed a zebrafish embryo model to assess the toxic effects of A. pseudoplatanus protoxins, HGA and MCPrG, as well as the toxic metabolite MCPA and to screen potential therapeutic compounds for Sapindaceae poisoning. Evaluations were conducted every 24 h over a 72 h period. Methylenecyclopropylglycine did not induce any toxic effects in zebrafish larvae, while HGA and its toxic metabolite, MCPA, exhibited significant toxic effects, allowing their LC50 and EC50 values to be determined.
Notably, the highest levels of MCPA–carnitine were detected 24 h after HGA exposure. The acylcarnitines profile, specifically C4, C6, C8, and C10, showed marked increases after 48 h. In contrast, C5 demonstrated a pronounced increase 24 h after exposure and maintained elevated levels at 48 h, confirming its potential as an early exposure biomarker in Sapindaceae poisoning [64].
Additionally, zebrafish larvae exposed to MCPA or HGA were utilised to screen the potential protective effects of molecules against AM. Among them, glycine and carnitine were effective in reducing mortality induced by MCPA and HGA, whereas riboflavin was not. This study introduces a novel model using zebrafish larvae and opens new perspectives for screening preventative or therapeutic compounds to mitigate AM-induced mortality.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29204954/s1, Figure S1: Picture of a 96-hour post-fertilization zebrafish larva of displaying a cardiac oedema after toxin exposure; Figure S2: Total swimming distance in four-day post-fertilization zebrafish larvae exposed to various concentrations of methylenecyclopropylacetate; Figure S3: Schematic of zebrafish movement during a 10 min dark and light photocycle; Table S1: List of the tested concentrations during the experiments.

Author Contributions

Conceptualisation, C.P.W., M.L.V. and D.-M.V.; methodology, C.P.W., B.K., N.P., F.B. and M.L.V.; software, C.P.W.; validation, C.P.W., M.L.V. and D.-M.V.; formal analysis, C.P.W.; investigation, C.P.W.; resources, D.-M.V.; data curation, C.P.W.; writing—original draft preparation, C.P.W.; writing—review and editing, C.P.W., N.P., F.B., M.L.V. and D.-M.V.; visualisation, C.P.W.; supervision, M.L.V. and D.-M.V.; project administration, D.-M.V.; funding acquisition, D.-M.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Wallonie agriculture SPW (Service public de Wallonie, Belgium) Grant No. D31-1381/S1-SAMA.

Institutional Review Board Statement

The committee in charge of animal experimentation was consulted with the case number n°22-2525. The committee approved the protocol on 19 December 2022.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

The authors thank Marine Joris to teach the manipulation of zebrafish larvae.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AMAtypical myopathy
C4Butyryl-/isobutyrylcarnitine
C4-OHHydroxy butyryl-/isobutyrylcarnitine
C4-DCSuccinyl-/methylmalonylcarnitine
C5Isovaleryl-/2-methylbutyrylcarnitine
C5:1Tiglycarnitine
C5-OHHydroxy isovalerylcarnitine
C5-DC Glutarylcarnitine
C6Hexanoylcarnitine
C8Octanoylcarnitine
C10Decanoylcarnitine
DMSODimethyl sulphoxide
N EC50Median effective concentration
HGAHypoglycin A
LC50Median lethal concentration
LC-MSLiquid chromatography–mass spectrometry
MCPAMethylenecyclopropylacetate
MCPA-CoAMethylenecyclopropylacetyl-CoA
MCPrGMethylenecyclopropylglycine
MS/MSTandem mass spectrometry
OECDOrganisation for Economic Co-operation and Development
RFTRange finding test
zFETZebrafish embryo toxicity

References

  1. Huybrechts, B.; Callebaut, A. Pyrrolizidine alkaloids in food and feed on the Belgian market. Food Addit. Contam. Part A 2015, 32, 1939–1951. [Google Scholar] [CrossRef] [PubMed]
  2. Fowden, L.; Pratt, H.M. Cyclopropylamino acids of the genus Acer: Distribution and biosynthesis. Phytochemistry 1973, 12, 1677–1681. [Google Scholar] [CrossRef]
  3. Sherratt, H. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit. Trends Pharmacol. Sci. 1986, 7, 186–191. [Google Scholar] [CrossRef]
  4. Spencer, P.S.; Palmer, V.S. The enigma of litchi toxicity: An emerging health concern in southern Asia. Lancet Glob. Health 2017, 5, e383–e384. [Google Scholar] [CrossRef] [PubMed]
  5. Valberg, S.J.; Sponseller, B.T.; Hegeman, A.D.; Earing, J.; Bender, J.B.; Martinson, K.L.; Patterson, S.E.; Sweetman, L. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree. EQuine Vet. J. 2013, 45, 419–426. [Google Scholar] [CrossRef]
  6. Unger, L.; Nicholson, A.; Jewitt, E.; Gerber, V.; Hegeman, A.; Sweetman, L.; Valberg, S. Hypoglycin A Concentrations in Seeds of Acer Pseudoplatanus Trees Growing on Atypical Myopathy-Affected and Control Pastures. J. Vet. Intern. Med. 2014, 28, 1289–1293. [Google Scholar] [CrossRef]
  7. Votion, D.M.; van Galen, G.; Sweetman, L.; Boemer, F.; de Tullio, P.; Dopagne, C.; Lefère, L.; Mouithys-Mickalad, A.; Patarin, F.; Rouxhet, S.; et al. Identification of methylenecyclopropyl acetic acid in serum of European horses with atypical myopathy. Equine Vet. J. 2014, 46, 146–149. [Google Scholar] [CrossRef]
  8. Westermann, C.; van Leeuwen, R.; van Raamsdonk, L.; Mol, H. Hypoglycin A Concentrations in Maple Tree Species in the Netherlands and the Occurrence of Atypical Myopathy in Horses. J. Vet. Intern. Med. 2016, 30, 880–884. [Google Scholar] [CrossRef]
  9. Boemer, F.; Detilleux, J.; Cello, C.; Amory, H.; Marcillaud-Pitel, C.; Richard, E.; van Galen, G.; van Loon, G.; Lefère, L.; Votion, D.M. Acylcarnitines profile best predicts survival in horses with atypical myopathy. PLoS ONE 2017, 12, e0182761. [Google Scholar] [CrossRef]
  10. Sander, J.; Terhardt, M.; Janzen, N.; Renaud, B.; Kruse, C.J.; François, A.C.; Wouters, C.P.; Boemer, F.; Votion, D.M. Tissue Specific Distribution and Activation of Sapindaceae Toxins in Horses Suffering from Atypical Myopathy. Animals 2023, 13, 2410. [Google Scholar] [CrossRef]
  11. van Galen, G.; Saegerman, C.; Marcillaud Pitel, C.; Patarin, F.; Amory, H.; Baily, J.D.; Cassart, D.; Gerber, V.; Hahn, C.; Harris, P.; et al. European outbreaks of atypical myopathy in grazing horses (2006–2009): Determination of indicators for risk and prognostic factors. Equine Vet. J. 2012, 44, 621–625. [Google Scholar] [CrossRef] [PubMed]
  12. van Galen, G.; Marcillaud Pitel, C.; Saegerman, C.; Patarin, F.; Amory, H.; Baily, J.D.; Cassart, D.; Gerber, V.; Hahn, C.; Harris, P.; et al. European outbreaks of atypical myopathy in grazing equids (2006–2009): Spatiotemporal distribution, history and clinical features. Equine Vet. J. 2012, 44, 614–620. [Google Scholar] [CrossRef] [PubMed]
  13. González-Medina, S.; Ireland, J.L.; Piercy, R.J.; Newton, J.R.; Votion, D.M. Equine atypical myopathy in the UK: Epidemiological characteristics of cases reported from 2011 to 2015 and factors associated with survival. Equine Vet. J. 2017, 49, 746–752. [Google Scholar] [CrossRef] [PubMed]
  14. Osmundsen, H.; Sherratt, H. A Novel mechanism for inhibition of β-oxidation by methylenecyclopropylacetyl-CoA, a metabolite of hypoglycin. FEBS Lett. 1975, 55, 38–41. [Google Scholar] [CrossRef]
  15. Chen, K.; Anderson, R.C.; McCowen, M.C.; Harris, P.N. Pharmacologic action of hypoglycin A and B. J. Pharmacol. Exp. Ther. 1957, 121, 272–285. [Google Scholar]
  16. Melde, K.; Jackson, S.; Bartlett, K.; Sherratt, H.; Ghisla, S. Metabolic consequences of methylenecyclopropylglycine poisoning in rats. Biochem. J. 1991, 274, 395–400. [Google Scholar] [CrossRef]
  17. Qiu, Y.; Perry, R.J.; Camporez, J.P.; Zhang, X.M.; Kahn, M.; Cline, G.; I. Shulman, G.; Vatner, D. In Vivo Studies on the Mechanism of Methylenecyclopropylacetic acid and Methylenecyclopropylglycine-Induced Hypoglycemia. Biochem. J. 2018, 475, BCJ20180063. [Google Scholar] [CrossRef]
  18. Delguste, C.; Baise, E.; Schwarzwald, C.C.; Sandersen, C.F.; Cassart, D.; Rollin, F.; Amory, H. Myopathies atypiques chez les chevaux au pré: Une série de cas en Belgique. Ann. Med. Vet. 2002, 146, 231–243. [Google Scholar] [CrossRef]
  19. Kruse, C.J.; Stern, D.; Mouithys-Mickalad, A.; Niesten, A.; Art, T.; Lemieux, H.; Votion, D.M. In Vitro Assays for the Assessment of Impaired Mitochondrial Bioenergetics in Equine Atypical Myopathy. Life 2021, 11, 719. [Google Scholar] [CrossRef]
  20. Wouters, C. Metabolomic/Lipidomic Investigations in Equine Atypical Myopathy and In Vitro Screening of Non-Pharmaceutical Compounds. Ph.D. Thesis, Univerity of Liège, Liège, Belgium, 2021. [Google Scholar]
  21. Tang, B.; More, V. Recent Advances in Drug Discovery Toxicology. Int. J. Toxicol. 2023, 42, 535–550. [Google Scholar] [CrossRef] [PubMed]
  22. Wang, L.; Hu, D.; Xu, J.; Hu, J.; Wang, Y. Complex in vitro model: A transformative model in drug development and precision medicine. Clin. Transl. Sci. 2024, 17, e13695. [Google Scholar] [CrossRef] [PubMed]
  23. Yang, A.; Lin, X.; Liu, Z.; Duan, X.; Yuan, Y.; Zhang, J.; Liang, Q.; Ji, X.; Sun, N.; Yu, H.; et al. Worm Generator: A System for High-Throughput in Vivo Screening. Nano Lett. 2023, 23, 1280–1288. [Google Scholar] [CrossRef] [PubMed]
  24. Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L.; et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496, 498–503. [Google Scholar] [CrossRef] [PubMed]
  25. Lubin, A.; Otterstrom, J.; Hoade, Y.; Bjedov, I.; Stead, E.; Whelan, M.; Gestri, G.; Paran, Y.; Payne, E. A versatile, automated and high-throughput drug screening platform for zebrafish embryos. Biol. Open 2021, 10, bio058513. [Google Scholar] [CrossRef] [PubMed]
  26. Dasgupta, S.; Simonich, M.T.; Tanguay, R.L. Developmental Toxicity Assessment Using Zebrafish-Based High-Throughput Screening. In Zebrafish: Methods and Protocols; Amatruda, J.F., Houart, C., Kawakami, K., Poss, K.D., Eds.; Springer: New York, NY, USA, 2024; pp. 71–82. [Google Scholar] [CrossRef]
  27. Truong, L.; Harper, S.L.; Tanguay, R.L. Evaluation of Embryotoxicity Using the Zebrafish Model. In Drug Safety Evaluation: Methods and Protocols; Gautier, J.C., Ed.; Humana Press: Totowa, NJ, USA, 2011; pp. 271–279. [Google Scholar] [CrossRef]
  28. McGrath, P.; Li, C.Q. Zebrafish: A predictive model for assessing drug-induced toxicity. Drug Discov. Today 2008, 13, 394–401. [Google Scholar] [CrossRef]
  29. MacRae, C.A.; Peterson, R.T. Zebrafish as tools for drug discovery. Nat. Rev. Drug Discov. 2015, 14, 721–731. [Google Scholar] [CrossRef]
  30. Bauer, B.; Mally, A.; Liedtke, D. Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing. Int. J. Mol. Sci. 2021, 22, 3417. [Google Scholar] [CrossRef]
  31. Silva Brito, R.; Canedo, A.; Farias, D.; Rocha, T.L. Transgenic zebrafish (Danio rerio) as an emerging model system in ecotoxicology and toxicology: Historical review, recent advances, and trends. Sci. Total Environ. 2022, 848, 157665. [Google Scholar] [CrossRef]
  32. Lu, P.H.; Lee, H.Y.; Liou, Y.L.; Tung, S.F.; Kuo, K.L.; Chen, Y.H. Nephroprotective Role of Zhibai Dihuang Wan in Aristolochic Acid-Intoxicated Zebrafish. BioMed Res. Int. 2020, 2020, 5204348. [Google Scholar] [CrossRef]
  33. Tsai, J.N.; Wang, Y.H.; Lin, P.J.; Chang, C.F.; Sun, C.Y.; Chen, Y.H. Nephroprotective effects of coriander (Coriandrum sativum) leaves aqueous extracts in aristolochic acid-intoxicated zebrafish embryos. Environ. Toxicol. 2024, 39, 4014–4021. [Google Scholar] [CrossRef]
  34. Bochnia, M.; Sander, J.; Ziegler, J.; Terhardt, M.; Sander, S.; Janzen, N.; Cavalleri, J.M.V.; Zuraw, A.; Wensch-Dorendorf, M.; Zeyner, A. Detection of MCPG metabolites in horses with atypical myopathy. PLoS ONE 2019, 14, e0211698. [Google Scholar] [CrossRef] [PubMed]
  35. Baker, K.; Warren, K.S.; Yellen, G.; Fishman, M.C. Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc. Natl. Acad. Sci. USA 1997, 94, 4554–4559. [Google Scholar] [CrossRef] [PubMed]
  36. Scott, J.A.; Incardona, J.P.; Pelkki, K.; Shepardson, S.; Hodson, P.V. AhR2-mediated, CYP1A-independent cardiovascular toxicity in zebrafish (Danio rerio) embryos exposed to retene. Aquat. Toxicol. 2011, 101, 165–174. [Google Scholar] [CrossRef] [PubMed]
  37. Wei, Y.; Meng, Y.; Huang, Y.; Liu, Z.; Zhong, K.; Ma, J.; Zhang, W.; Li, Y.; Lu, H. Development toxicity and cardiotoxicity in zebrafish from exposure to iprodione. Chemosphere 2021, 263, 127860. [Google Scholar] [CrossRef] [PubMed]
  38. Votion, D.M.; Linden, A.; Saegerman, C.; Engels, P.; Erpicum, M.; Thiry, E.; Delguste, C.; Rouxhet, S.; Demoulin, V.; Navet, R.; et al. History and Clinical Features of Atypical Myopathy in Horses in Belgium (2000–2005). J. Vet. Intern. Med. 2007, 21, 1380–1391. [Google Scholar] [CrossRef]
  39. Lu, H.; Shagirova, A.; Goggi, J.; Yeo, H.; Roy, S. Reissner fibre-induced urotensin signalling from cerebrospinal fluid-contacting neurons prevents scoliosis of the vertebrate spine. Biol. Open 2020, 9, bio052027. [Google Scholar] [CrossRef]
  40. Ikeda, Y.; Tanaka, K. Selective inactivation of various acyl-CoA dehydrogenases by (methylenecyclopropyl)acetyl-CoA. Biochim. Biophys. Acta (BBA)—Protein Struct. Mol. Enzymol. 1990, 1038, 216–221. [Google Scholar] [CrossRef]
  41. Lai, M.T.; Li, D.; Oh, E.; Liu, H.W. Inactivation of medium-chain acyl-CoA dehydrogenase by a metabolite of hypoglycin: Characterization of the major turnover product and evidence suggesting an alternative flavin modification pathway. J. Am. Chem. Soc. 1993, 115, 1619–1628. [Google Scholar] [CrossRef]
  42. Westermann, C.M.; Dorland, L.; Votion, D.M.; de Sain-van der Velden, M.G.M.; Wijnberg, I.D.; Wanders, R.J.A.; Spliet, W.G.M.; Testerink, N.; Berger, R.; Ruiter, J.P.N.; et al. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul. Disord. 2008, 18, 355–364. [Google Scholar] [CrossRef]
  43. Sander, J.; Terhardt, M.; Janzen, N. Study on the Metabolic Effects of Repeated Consumption of Canned Ackee. J. Agric. Food Chem. 2020, 68, 14603–14609. [Google Scholar] [CrossRef] [PubMed]
  44. Böhme, S.; Stärk, H.J.; Reemtsma, T.; Kühnel, D. Effect propagation after silver nanoparticle exposure in zebrafish (Danio rerio) embryos: A correlation to internal concentration and distribution patterns. Environ. Sci. Nano 2015, 2, 603–614. [Google Scholar] [CrossRef]
  45. Pelka, K.E.; Henn, K.; Keck, A.; Sapel, B.; Braunbeck, T. Size does matter—Determination of the critical molecular size for the uptake of chemicals across the chorion of zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2017, 185, 1–10. [Google Scholar] [CrossRef] [PubMed]
  46. Bar-Ilan, O.; Louis, K.M.; Yang, S.P.; Pedersen, J.A.; Hamers, R.J.; Peterson, R.E.; Heideman, W. Titanium dioxide nanoparticles produce phototoxicity in the developing zebrafish. Nanotoxicology 2012, 6, 670–679. [Google Scholar] [CrossRef] [PubMed]
  47. Creton, R. The calcium pump of the endoplasmic reticulum plays a role in midline signaling during early zebrafish development. Dev. Brain Res. 2004, 151, 33–41. [Google Scholar] [CrossRef] [PubMed]
  48. Henn, K.; Braunbeck, T. Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Comp. Biochem. Physiol. Part Toxicol. Pharmacol. 2011, 153, 91–98. [Google Scholar] [CrossRef]
  49. Kim, K.T.; Tanguay, R.L. The role of chorion on toxicity of silver nanoparticles in the embryonic zebrafish assay. Environ. Anal. Health Toxicol. 2014, 29, e2014021. [Google Scholar] [CrossRef]
  50. Lamprea, M.R.; Cardenas, F.P.; Setem, J.; Morato, S. Thigmotactic responses in an open-field. Braz. J. Med. Biol. Res. 2008, 41, 135–140. [Google Scholar] [CrossRef]
  51. Simon, P.; Dupuis, R.; Costentin, J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav. Brain Res. 1994, 61, 59–64. [Google Scholar] [CrossRef]
  52. OECD. Test No. 236: Fish Embryo Acute Toxicity (FET) Test, OECD Guidelines for the Testing of Chemicals, Section 2; OECD Publishing: Paris, France, 2013. [Google Scholar]
  53. Votion, D.M. Analysing hypoglycin A, methylenecyclopropylacetic acid conjugates and acylcarnitines in blood to confirm the diagnosis and improve our understanding of atypical myopathy. Equine Vet. Educ. 2018, 30, 29–30. [Google Scholar] [CrossRef]
  54. Fabius, L.S.; Westermann, C.M. Evidence-based therapy for atypical myopathy in horses. Equine Vet. Educ. 2018, 30, 616–622. [Google Scholar] [CrossRef]
  55. Brooks, S.E.H.; Audretsch, J.J. The protective effects of feeding on the hepatic ultrastructure of rats treated with hypoglycin. J. Pathol. 1971, 104, 167–174. [Google Scholar] [CrossRef] [PubMed]
  56. Boemer, F.; Deberg, M.; Schoos, R.; Baise, E.; Amory, H.; Gault, G.; Carlier, J.; Gaillard, Y.; Marcillaud-Pitel, C.; Votion, D. Quantification of hypoglycin A in serum using aTRAQ® assay. J. Chromatogr. B 2015, 997, 75–80. [Google Scholar] [CrossRef] [PubMed]
  57. MacPhail, R.; Brooks, J.; Hunter, D.; Padnos, B.; Irons, T.; Padilla, S. Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology 2009, 30, 52–58. [Google Scholar] [CrossRef] [PubMed]
  58. Pohl, J. Zebrafish (Danio rerio) embryo-larvae locomotor activity data analysis: Evaluating anxiolytic effects of the antidepressant compound citalopram. Data Brief 2019, 27, 104812. [Google Scholar] [CrossRef] [PubMed]
  59. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021. [Google Scholar]
  60. RStudio Team. RStudio: Integrated Development for R. RStudio; RStudio Team: Boston, MA, USA, 2015. [Google Scholar]
  61. Ritz, C.; Baty, F.; Streibig, J.C.; Gerhard, D. Dose-Response Analysis Using R. PLoS ONE 2015, 10, e0146021. [Google Scholar] [CrossRef]
  62. Wickham, H. ggplot2: Elegant Graphics for Data Analysis; Springer: New York, NY, USA, 2016. [Google Scholar]
  63. Hothorn, T.; Bretz, F.; Westfall, P. Simultaneous Inference in General Parametric Models. Biom. J. 2008, 50, 346–363. [Google Scholar] [CrossRef]
  64. Renaud, B.; Kruse, C.J.; François, A.C.; Cesarini, C.; van Loon, G.; Palmers, K.; Boemer, F.; Luis, G.; Gustin, P.; Votion, D.M. Large-scale study of blood markers in equine atypical myopathy reveals subclinical poisoning and advances in diagnostic and prognostic criteria. Environ. Toxicol. Pharmacol. 2024, 110, 104515. [Google Scholar] [CrossRef]
Figure 1. Lethality and sub-lethal effects of zebrafish embryos exposed to various concentrations of A. pseudoplatanus toxins, hypoglycin A, and methelynecyclopropylacetate over 72 h. The experiment was conducted to determine the median lethal (LC50) and median sub-lethal (EC50) concentration for hypoglycin A (A) and methelynecyclopropylacetate (B) at 24, 48, and 72 h post-exposure. Data were obtained from three independent replicates with 20 embryos per concentration per replicate. The LC50 and EC50 values were calculated using a four-parameter log-logistic model implemented with the drc R package, along with the associated standard error and the p-value. The sample size was 60 individuals per concentration (3 trials × 20 individuals), and the statistical test was a logistic regression with four parameters.
Figure 1. Lethality and sub-lethal effects of zebrafish embryos exposed to various concentrations of A. pseudoplatanus toxins, hypoglycin A, and methelynecyclopropylacetate over 72 h. The experiment was conducted to determine the median lethal (LC50) and median sub-lethal (EC50) concentration for hypoglycin A (A) and methelynecyclopropylacetate (B) at 24, 48, and 72 h post-exposure. Data were obtained from three independent replicates with 20 embryos per concentration per replicate. The LC50 and EC50 values were calculated using a four-parameter log-logistic model implemented with the drc R package, along with the associated standard error and the p-value. The sample size was 60 individuals per concentration (3 trials × 20 individuals), and the statistical test was a logistic regression with four parameters.
Molecules 29 04954 g001
Figure 2. Time course of HGA and MCPA–carnitine concentrations in zebrafish larvae (24 hpf) after intoxication with HGA and MCPA. Hypoglycin A ( μ mol/L) and MCPA–carnitine (nmol/L) concentrations in the zebrafish larvae whole body after intoxication with hypoglycin A in (A,B), respectively, after MCPA exposure in (C,D), respectively. Hypoglycin A ( μ mol/L) and MCPA–carnitine (nmol/L) concentrations in the E3 medium surrounding the zebrafish larvae after intoxication with HGA in (E,F), respectively. The sample size was 20 individuals per concentration (1 trial × 20 individuals). HGA: hypoglycin A; MCPA: methylenecyclopropylacetate.
Figure 2. Time course of HGA and MCPA–carnitine concentrations in zebrafish larvae (24 hpf) after intoxication with HGA and MCPA. Hypoglycin A ( μ mol/L) and MCPA–carnitine (nmol/L) concentrations in the zebrafish larvae whole body after intoxication with hypoglycin A in (A,B), respectively, after MCPA exposure in (C,D), respectively. Hypoglycin A ( μ mol/L) and MCPA–carnitine (nmol/L) concentrations in the E3 medium surrounding the zebrafish larvae after intoxication with HGA in (E,F), respectively. The sample size was 20 individuals per concentration (1 trial × 20 individuals). HGA: hypoglycin A; MCPA: methylenecyclopropylacetate.
Molecules 29 04954 g002
Figure 3. Time course of acylcarnitines concentrations in the whole body of zebrafish larvae after exposure with 100 μ M of hypoglycin A. Concentrations of four-carbon chain length in (A), five-carbon chain length acylcarnitines in (B), even-numbered acylcarnitines in (C) and short- and medium chain acylcarnitines in (D). The sample size was 20 individuals per concentration (1 trial × 20 individuals). DC: dicarboxylic.
Figure 3. Time course of acylcarnitines concentrations in the whole body of zebrafish larvae after exposure with 100 μ M of hypoglycin A. Concentrations of four-carbon chain length in (A), five-carbon chain length acylcarnitines in (B), even-numbered acylcarnitines in (C) and short- and medium chain acylcarnitines in (D). The sample size was 20 individuals per concentration (1 trial × 20 individuals). DC: dicarboxylic.
Molecules 29 04954 g003
Figure 4. Total swimming distance in four-day post-fertilisation zebrafish larvae exposed to various concentrations of methylenecyclopropylacetate from 72 to 96 h post-fertilisation. The sample size was 12 individuals per concentration in (A,B) and 24 individuals per concentration in (C,D). (*: p < 0.05, ***: p < 0.001 according to one-way ANOVA and Dunnett’s post hoc test). MCPA: methylenecyclopropylacetate; Ctl+: 3,4-dichloroaniline.
Figure 4. Total swimming distance in four-day post-fertilisation zebrafish larvae exposed to various concentrations of methylenecyclopropylacetate from 72 to 96 h post-fertilisation. The sample size was 12 individuals per concentration in (A,B) and 24 individuals per concentration in (C,D). (*: p < 0.05, ***: p < 0.001 according to one-way ANOVA and Dunnett’s post hoc test). MCPA: methylenecyclopropylacetate; Ctl+: 3,4-dichloroaniline.
Molecules 29 04954 g004
Figure 5. Assessment of riboflavin, carnitine, and glycine co-treatment effects on the mortality of zebrafish larvae in the presence of MCPA (in (A)) or HGA (in (B)) after 72 h of exposure. The absolute number of larval deaths is indicated above each bar. MCPA: methylenecyclopropylacetate; HGA: hypoglycin A.
Figure 5. Assessment of riboflavin, carnitine, and glycine co-treatment effects on the mortality of zebrafish larvae in the presence of MCPA (in (A)) or HGA (in (B)) after 72 h of exposure. The absolute number of larval deaths is indicated above each bar. MCPA: methylenecyclopropylacetate; HGA: hypoglycin A.
Molecules 29 04954 g005
Table 1. List of tested molecules.
Table 1. List of tested molecules.
Supplier Name 1Chemical Structure 2Supplier (Cas Number)Purity
(S)-Hypoglycin AMolecules 29 04954 i001Toronto Research Chemicals (156-56-9)85%
α -(Methylenecyclopropyl)glycine (mixture of diastereomers)Molecules 29 04954 i002Toronto Research Chemicals (2517-07-9)97%
(RS)-(Methylenecyclopropyl)acetic acidMolecules 29 04954 i003Sigma-Aldrich (1073-00-3)≥95%
1 The molecules were abbreviated as HGA, MCPrG, and MCPA, respectively. 2 Chemical structures were taken from the suppliers’ respective website www.trc-canada.com; www.sigmaaldrich.com; all accessed on 4 July 2023.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wouters, C.P.; Klein, B.; Price, N.; Boemer, F.; Voz, M.L.; Votion, D.-M. A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning. Molecules 2024, 29, 4954. https://doi.org/10.3390/molecules29204954

AMA Style

Wouters CP, Klein B, Price N, Boemer F, Voz ML, Votion D-M. A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning. Molecules. 2024; 29(20):4954. https://doi.org/10.3390/molecules29204954

Chicago/Turabian Style

Wouters, Clovis P., Benjamin Klein, Nicholas Price, François Boemer, Marianne L. Voz, and Dominique-Marie Votion. 2024. "A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning" Molecules 29, no. 20: 4954. https://doi.org/10.3390/molecules29204954

APA Style

Wouters, C. P., Klein, B., Price, N., Boemer, F., Voz, M. L., & Votion, D. -M. (2024). A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning. Molecules, 29(20), 4954. https://doi.org/10.3390/molecules29204954

Article Metrics

Back to TopTop